logo-loader
viewOpen Orphan PLC

Venn Life Sciences (LON:VENN) - Investor Presentation - July 2nd 2015

microphone_55afb015824d5.png

Venn Life Sciences (LON:VENN) - Investor Presentation - July 2nd 2015

Quick facts: Open Orphan PLC

Price: 6.4 GBX

AIM:ORPH
Market: AIM
Market Cap: £35.14 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Venn Life CEO Richardson comments on Kinesis deal

Tony Richardson, chief executive Venn Life Sciences (LON:VENN), says the company’s acquisition of Dutch drug consultancy Kinesis allows it to pair early and late-stage drug development together. Venn currently offers clinical trial management, monitoring and biometric data services to...

on 09/22/2015

2 min read